MICHAEL ZARILLA: Open Payments
NPI 1386865574 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,624 in 80 payments from 24 companies in 2025. Trend: 2023 $1,631 · 2024 $1,480 · 2025 $1,624
Food & beverage: $1,624
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 19 | $350 |
| Novo Nordisk Inc | 10 | $200 |
| ABBVIE INC. | 8 | $176 |
| PFIZER INC. | 9 | $172 |
| AstraZeneca Pharmaceuticals LP | 5 | $156 |
| Lilly USA, LLC | 4 | $85 |
| Tandem Diabetes Care, Inc. | 3 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Amgen Inc. | 2 | $39 |
Products named: Korlym, QULIPTA, FARXIGA, ELIQUIS, Rybelsus, Ozempic, JARDIANCE, UBRELVY.
Industry payments across FL — which companies pay providers there.
